These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 31286212)

  • 21. Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease.
    German CL; Baladi MG; McFadden LM; Hanson GR; Fleckenstein AE
    Pharmacol Rev; 2015 Oct; 67(4):1005-24. PubMed ID: 26408528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monoamine transporter as a target molecule for psychostimulants.
    Sora I; Li B; Fumushima S; Fukui A; Arime Y; Kasahara Y; Tomita H; Ikeda K
    Int Rev Neurobiol; 2009; 85():29-33. PubMed ID: 19607959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mood stabilizer lithium inhibits amphetamine-increased 4-hydroxynonenal-protein adducts in rat frontal cortex.
    Tan H; Young LT; Shao L; Che Y; Honer WG; Wang JF
    Int J Neuropsychopharmacol; 2012 Oct; 15(9):1275-85. PubMed ID: 21939588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of amphetamine action illuminated through optical monitoring of dopamine synaptic vesicles in Drosophila brain.
    Freyberg Z; Sonders MS; Aguilar JI; Hiranita T; Karam CS; Flores J; Pizzo AB; Zhang Y; Farino ZJ; Chen A; Martin CA; Kopajtic TA; Fei H; Hu G; Lin YY; Mosharov EV; McCabe BD; Freyberg R; Wimalasena K; Hsin LW; Sames D; Krantz DE; Katz JL; Sulzer D; Javitch JA
    Nat Commun; 2016 Feb; 7():10652. PubMed ID: 26879809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter.
    Jones SR; Gainetdinov RR; Wightman RM; Caron MG
    J Neurosci; 1998 Mar; 18(6):1979-86. PubMed ID: 9482784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of amphetamine on subcellular distribution of dopamine and DOPAC.
    Wallace LJ
    Synapse; 2012 Jul; 66(7):592-607. PubMed ID: 22314940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter.
    Pifl C; Reither H; Hornykiewicz O
    Eur J Pharmacol; 2015 May; 755():119-26. PubMed ID: 25771452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of monoamine transporters: influence of psychostimulants and therapeutic antidepressants.
    Jayanthi LD; Ramamoorthy S
    AAPS J; 2005 Oct; 7(3):E728-38. PubMed ID: 16353949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AAH2 gene is not required for dopamine-dependent neurochemical and behavioral abnormalities produced by Toxoplasma infection in mouse.
    McFarland R; Wang ZT; Jouroukhin Y; Li Y; Mychko O; Coppens I; Xiao J; Jones-Brando L; Yolken RH; Sibley LD; Pletnikov MV
    Behav Brain Res; 2018 Jul; 347():193-200. PubMed ID: 29555339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine.
    Wang YM; Gainetdinov RR; Fumagalli F; Xu F; Jones SR; Bock CB; Miller GW; Wightman RM; Caron MG
    Neuron; 1997 Dec; 19(6):1285-96. PubMed ID: 9427251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of amphetamines and related compounds at the vesicular monoamine transporter.
    Partilla JS; Dempsey AG; Nagpal AS; Blough BE; Baumann MH; Rothman RB
    J Pharmacol Exp Ther; 2006 Oct; 319(1):237-46. PubMed ID: 16835371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopamine transporter activity mediates amphetamine-induced inhibition of Akt through a Ca2+/calmodulin-dependent kinase II-dependent mechanism.
    Wei Y; Williams JM; Dipace C; Sung U; Javitch JA; Galli A; Saunders C
    Mol Pharmacol; 2007 Mar; 71(3):835-42. PubMed ID: 17164407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phosphorylation of the Amino Terminus of the Dopamine Transporter: Regulatory Mechanisms and Implications for Amphetamine Action.
    Karam CS; Javitch JA
    Adv Pharmacol; 2018; 82():205-234. PubMed ID: 29413521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. G protein-coupled receptor signaling in VTA dopaminergic neurons bidirectionally regulates the acute locomotor response to amphetamine but does not affect behavioral sensitization.
    Runegaard AH; Dencker D; Wörtwein G; Gether U
    Neuropharmacology; 2019 Dec; 161():107663. PubMed ID: 31173760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoamine transporters and psychostimulant addiction.
    Howell LL; Kimmel HL
    Biochem Pharmacol; 2008 Jan; 75(1):196-217. PubMed ID: 17825265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deletion of the vesicular monoamine transporter 1 (vmat1/slc18a1) gene affects dopamine signaling.
    Lohoff FW; Carr GV; Brookshire B; Ferraro TN; Lucki I
    Brain Res; 2019 Jun; 1712():151-157. PubMed ID: 30685272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The dopamine transporter expression level differentially affects responses to cocaine and amphetamine.
    Cagniard B; Sotnikova TD; Gainetdinov RR; Zhuang X
    J Neurogenet; 2014; 28(1-2):112-21. PubMed ID: 24673634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simple transporter trafficking model for amphetamine-induced dopamine efflux.
    Thwar PK; Guptaroy B; Zhang M; Gnegy ME; Burns MA; Linderman JJ
    Synapse; 2007 Jul; 61(7):500-14. PubMed ID: 17415796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic methylphenidate preferentially alters catecholamine protein targets in the parietal cortex and ventral striatum.
    Quansah E; Zetterström TSC
    Neurochem Int; 2019 Mar; 124():193-199. PubMed ID: 30660754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential role of tyrosine hydroxylase in the loss of psychostimulant effect of amphetamine under conditions of impaired dopamine transporter activity.
    Janenaite E; Vengeliene V; Bespalov A; Behl B
    Behav Brain Res; 2017 Sep; 334():105-108. PubMed ID: 28750831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.